Tumefactive demyelinating lesions are an uncommon manifestation of demyelinating disease that mimic primary central nervous system neoplasms and can pose a diagnostic challenge in patients without a pre-existing diagnosis of multiple sclerosis. Although a biopsy may be required to distinguish TDL from neoplasms or infection, certain ancillary and radiographic findings may preclude the need for invasive diagnostic procedures. We describe the case of a 15-year-old boy with a tumefactive demyelinating lesion involving the conus medullaris. An exhaustive systematic literature search of pediatric cases of TDL yielded an additional 78 cases. This review summarizes the current knowledge and recommendations for the diagnosis and management of this condition, highlighting the clinical, demographic, and radiologic features of 79 reported cases, including our own. Furthermore, it underscores areas of the literature where evidence is still lacking. Further research is needed to optimize clinical detection and medical management of this condition.
YaoJYeungYWaubantEZhangJLLanger-GouldAChungJ. Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children. Neurology. 2011;77(12):1143–1148. doi:10.1212/wnl.0b013e31822facdd
2.
GeY. Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol. 2006;27(6):1165–1176. doi:27/6/1165 [pii]
3.
TotaroRDi CarmineCMariniCCaroleiA. Tumefactive demyelinating lesions: spectrum of disease, diagnosis and treatment. Curr Neurobiol. 2016;7(1):21–26. doi:10.4172/0975-9042.000113
4.
AlgahtaniHShirahBAlassiriA. Tumefactive demyelinating lesions: a comprehensive review. Mult Scler Relat Disord. 2017;14(April):72–79. doi:10.1016/j.msard.2017.04.003
5.
YaghiSGokdinMSethiH. Tumefactive demyelination of the spinal cord. Acta Neurol Belg. 2010;110(2):206–208.
6.
SheikhZWangWRavalBOlangoWHillenM. Tumefactive Demyelinating Lesion (TDL) of Spinal Cord due to Aquaporin-4 Ab. In: Annual Meeting of the Consortium of the Multiple Sclerosis Centers. Indianapolis, IN; 2015.
7.
KantorováEMacinekJZeleňákKKantorKMichalikL. Tumefactive demyelination of the spinal cord: a case report. Spinal Coprd. 2015;53:877–880.
8.
WingerchukDMBanwellBBennettJL, et al.International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–189. doi:10.1212/WNL.0000000000001729
9.
DiMarioFJHajjarMCiesielskiTA. Erratum: a 16-year-old girl with bilateral visual loss and left hemiparesis following an immunization against human papilloma virus. (Journal of Child Neurology 2010 (25) 321-327)). J Child Neurol. 2010;25(5):656. doi:10.1177/0883073810368052
10.
DastgirJDiMarioFJ. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal. J Child Neurol. 2009;24(4):431–437. doi:10.1177/0883073808324769
11.
ZagzagDMillerDCKleinmanGMAbatiADonnenfeldHBudzilovichGN. Demyelinating disease versus tumor in surgical neuropathology: clues to a correct pathological diagnosis. Am J Surg Pathol. 1993;17(6):537–545. doi:10.1097/00000478-199306000-00001
12.
GiangDPoduriKEskinT. Multiple sclerosis masquerading as a mass lesion. Neuroradiology. 1992;34:150–154.
YoulBDKermodeAGThompsonAJ, et al.Destructive lesions in demyelinating disease. J Neurol Neurosurg Psychiatry. 1991;54(4):288–292. doi:10.1136/jnnp.54.4.288
15.
Al-BunyanMA. Tumor-like presentation of multiple sclerosis. Saudi Med J. 2000;21(4):393–395.
16.
KepesJ. Large focal tumor-like demyelinating lesions of the brain: intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Neurology. 1993;33:18–27.
17.
BanwellBShroffMNessJ, et al.MRI features of pediatric multiple sclerosis. Neurology. 2007;68(Suppl 2):S46–S53.
18.
HinnellCJLuJQRajapakseTMahJK. Acute tumefactive inflammatory demyelination in a child. Pediatr Neurol. 2011;44(5):394–395. doi:10.1016/j.pediatrneurol.2011.01.013
19.
VanlandinghamMHaniganWVedanarayananVFratkinJ. An uncommon illness with a rare presentation: neurosurgical management of ADEM with tumefactive demyelination in children. Child’s Nerv Syst. 2010;26(5):655–661. doi:10.1007/s00381-009-1045-x
20.
HanumantheSBFranciscoCHartJGravesJWaubantE. Biopsy-supported tumefactive demyelination of the central nervous system in children. J Child Neurol. 2016;31(14):1528–1533. doi:10.1177/0883073816664667
21.
RivaDChiappariniLPolloBBalestriniMRMassiminoMMilaniN. A case of pediatric tumefactive demyelinating lesion misdiagnosed and treated as glioblastoma. J Child Neurol. 2008;23(8):944–947. doi:10.1177/0883073808315419
22.
MalhotraHSJainKKAgarwalA, et al.Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler. 2009;15(2):193–203. doi:10.1177/1352458508097922
23.
YiuEMLaughlinSVerheyLHBanwellBL. Clinical and magnetic resonance imaging (MRI) distinctions between tumefactive demyelination and brain tumors in children. J Child Neurol. 2014;29(5):654–665. doi:10.1177/0883073813500713
24.
AndersonRCEConnollyESKomotarRJ, et al.Clinicopathological review: tumefactive demyelination in a 12-year-old girl. Neurosurgery. 2005;56(5):1051–1056. doi:10.1227/01.NEU.0000158194.51833.64
25.
Van ToornRSchoemanJFSolomonsRRensburgMAVan RensburgSJ. Iron status in children with recurrent episodes of tumefactive cerebral demyelination. J Child Neurol. 2010;25(11):1401–1407. doi:10.1177/0883073810366179
26.
KalanieHHarandiAABakhshandehpourRHeidariD. Multiple large tumefactive MS plaques in a young man: a diagnostic enigma and therapeutic challenge. Case Rep Radiol. 2012;2012:1–5. doi:10.1155/2012/363705
27.
AbdoliMFreedmanMS. Neuro-oncology dilemma: tumour or tumefactive demyelinating lesion. Mult Scler Relat Disord. 2015;4(6):555–566. doi:10.1016/j.msard.2015.07.013
28.
De SimoneMBrognaBSpitaleriDLCicarelliGFantozziRGuidaB. Progression of tumefactive demyelinating lesion in a child demonstrated with MRI. Radiol Case Rep. 2018;13(1):254–260. doi:10.1016/j.radcr.2017.10.026
ZalneraitisELVonsattelJP. A 15-year-old girl with hemiparesis, slurred speech, and an intracranial lesion. N Engl J Med. 1998;339(8):542–549.
33.
PetersonKRosenblumMPowersJ. Effect of brain irradiation on demyelinating lesions. Neurology. 1993;43:2105–2112.
34.
NeelimaRKrishnakumarKNairMKesavadasC. Tumefactive demyelinating lesions: a clinicopathological correlative study. Indian J Pathol Microbiol. 2012;55(4):496–500.
35.
AshrafiMRTavasoliARAlizadehHZare NoghabiJParvanehN. Tumefactive multiple sclerosis variants: report of two cases of Schilder and Balo diseases. Iran J Child Neurol. 2017;11(2):69–77. doi:10.22037/ijcn.v11i2.10713
36.
JainRSKhanIKandelwalKDesaiT. Tumefactive demyelinating lesions (TDLs): a case series of clinicoradiological features. Clin Neurol Neurosurg. 2017;162(September):91–94. doi:10.1016/j.clineuro.2017.09.013
37.
XiaLLinSWangZC, et al.Tumefactive demyelinating lesions: nine cases and a review of the literature. Neurosurg Rev. 2009;32(2):171–179. doi:10.1007/s10143-009-0185-5
KimHJLeeSMKimHDLeeJSKangHC. Schilder’s disease in a young child with tumefactive demyelinating brain lesion. Neurol Asia. 2013;18(4):419–421.
41.
LinWSKuoMFPengSSFFanPC. Long-term outcome of Schilder disease treated with interferon-β. Pediatrics. 2019;144(5). doi:10.1542/peds.2019-0505
42.
BiswasSNagarajCMangaloreSGuptaAK. Tumefactive demyelination versus primary central nervous system lymphoma on 18F-fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a twist in the tale. Indian J Nucl Med. 2019;34(3):237–240.
43.
McAdamLCBlaserSIBanwellBL. Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol. 2002;26(1):18–25. doi:10.1016/S0887-8994(01)00322-8
44.
KumarKTothCJayV. Focal plaque of demyelination mimicking cerebral tumor in a pediatric patient. Pediatr Neurosurg. 1998;29:60–63.
45.
MetafratziZArgyropoulouMITzoufiMPapadopoulouZEfremidisSC. Conventional MRI and magnetisation transfer imaging of tumour-like multiple sclerosis in a child. Neuroradiology. 2002;44(1):97–99. doi:10.1007/s002340100704
46.
RusinJAVezinaLGChadduckWMChandraRS. Tumoral multiple sclerosis of the cerebellum in a child. Am J Neuroradiol. 1995;16(5):1164–1166.
47.
YapiciZEraksoyM. Bilateral demyelinating tumefactive lesions in three children with hemiparesis. J Child Neurol. 2003;17(9):655–660. doi:10.1177/088307380201700901
48.
PuriVChaudhryNGulatiPTatkeMSinghD. Recurrent tumefactive demyelination in a child. J Clin Neurosci. 2005;12(4):495–500. doi:10.1016/j.jocn.2004.07.001
49.
SánchezPMeca-LallanaVBarbosaAManzanaresRPalmíIVivancosJ. Tumefactive demyelinating lesions of 15 patients: clinico-radiological features, management and review of the literature. J Neurol Sci. 2017;381:32–38.
50.
Dos PassosGROliveiraLMda CostaBK, et al.MOG-IgG-associated optic neuritis, encephalitis, and myelitis: lessons learned from neuromyelitis optica spectrum disorder. Front Neurol. 2018;9:217. doi:10.3389/fneur.2018.00217
51.
KitleyJLLeiteMIGeorgeJSPalaceJA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler J. 2012;18(3):271–285. doi:10.1177/1352458511406165
52.
SatoDKCallegaroDLana-PeixotoMA, et al.Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology. 2014;82(6):474–481. doi:10.1212/WNL.0000000000000101
53.
BrodSALindseyJWNelsonF. Tumefactive demyelination: clinical outcomes, lesion evolution and treatments. Mult Scler J Exp Transl Clin. 2019;5(2):205521731985575. doi:10.1177/2055217319855755
54.
KimDSNaDGKimKH, et al.Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging. Radiology. 2009;251(2):467–475. doi:10.1148/radiol.2512072071
55.
MeuriceAFlandroyPDondelingerRFReznikM. A single focus of probable multiple sclerosis in the cervical spinal cord mimicking a tumour. Neuroradiology. 1994;36:234–235.
56.
MaezawaHTakanoMNagaiSIidaHTachibanaS. Spinal multiple sclerosis mimicking a spinal cord tumor: a case report. No Shinkei Geka. 1995;23(11):1007–1010.
57.
SilvaHCCallegaroDMarchioriPEScaffMTsanaclisAMC. Magnetic resonance imaging in five patients with a tumefactive demyelinating lesion in the central nervous system. Arq Neuropsiquiatr. 1999;57(4):921–926. doi:10.1590/s0004-282x1999000600004
58.
ChanJCXChiMSYeungTWChanELYNgSHWongYC. Brainstem Mimicking Abscess: A Case Report. 2019:1–4.
59.
YaghiSGokdinMSethiH. Tumefactive demyelination of the spinal cord. Acta Neurol Belg. 2010;110:206–208.
60.
BravermanDLLachmannEATunkelRNaglerW. Multiple sclerosis presenting as a spinal cord tumor. Arch Phys Med Rehabil. 1997;78:1274–1276.
61.
MakaryMSKirshCF. Tumefactive demyelinating disease with isolated spinal cord involvement. Acta Radiol Short Rep. 2014;3(5):2047981614539324.
62.
SoaresBPChabasDWintermarkM. MRI features of pediatric multiple sclerosis. Demyelinating Disord Cent Nerv Syst Child. 2011:48–57. doi:10.1017/CBO9780511974373.006
63.
Deckert-SchlüterMSchlüterDHofHWiestlerODLassmannH.Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J Neuropathol Exp Neurol. 1994. doi:10.1097/00005072-199409000-00005.
MurphyCBHashimotoSAGraebDThiessenBA. Clinical exacerbation of multiple sclerosis following radiotherapy. Arch Neurol. 2003;60(2):273–275. doi:10.1001/archneur.60.2.273
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
